Laryngeal Disorders and GERD in Assiut University

Sponsor
Assiut University (Other)
Overall Status
Completed
CT.gov ID
NCT04231344
Collaborator
(none)
100
1
13
7.7

Study Details

Study Description

Brief Summary

Study laryngeal disorders by laryngoscopic examination by two physicians on GERD patients diagnosed by gastroenterology department by endoscopy and effect of GERD treatment for 3 months on these laryngeal disorders without any treatment to laryngeal disorders

Condition or Disease Intervention/Treatment Phase
  • Device: Laryngoscopy

Study Design

Study Type:
Observational
Actual Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Prevalence of Laryngeal Disorders in Patients With GERD in Assiut University Hospital
Actual Study Start Date :
Jan 1, 2021
Actual Primary Completion Date :
May 1, 2021
Actual Study Completion Date :
Feb 1, 2022

Outcome Measures

Primary Outcome Measures

  1. Prevalence of laryngeal disorders in GERD patients [One year from February 2020 to February 2021]

    Laryngoscopic examination of patients with GERD by two otorhinolaryngologist physicians

Secondary Outcome Measures

  1. Effect of treatment of GERD on these laryngeal disorders [3 months]

    Treatment of GERD by gastroenterology department for 3 months and reexamination of patients by laryngoscopy for laryngeal disorders without any treatment to laryngeal disorders

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Patients diagnosed GERD by gastroenterology department before start of treatment and have laryngeal symptoms

Exclusion Criteria:
  • voice abusers as singers ,teachers and readers.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Assiut university Assiut Egypt 71515

Sponsors and Collaborators

  • Assiut University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
SHimaa Salah Sadek, Principle investigator, Assiut University
ClinicalTrials.gov Identifier:
NCT04231344
Other Study ID Numbers:
  • LPRD
First Posted:
Jan 18, 2020
Last Update Posted:
Mar 28, 2022
Last Verified:
Mar 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 28, 2022